Last reviewed · How we verify
A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg or Placebo When Co-administered With Statins in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with statins on cholesterol levels in subjects with hypercholesterolemia
Details
| Lead sponsor | Takeda |
|---|---|
| Phase | Phase 3 |
| Status | TERMINATED |
| Enrolment | 411 |
| Start date | 2007-07 |
| Completion | 2008-04 |
Conditions
- Hypercholesterolemia
Interventions
- Lapaquistat acetate and stable statin therapy
- Stable statin therapy
Primary outcomes
- Change from Baseline in fasting plasma Low Density Lipoprotein cholesterol — Week 12 or Final Visit
Countries
United States